Serum thromboxane-B2 (TxB2), together with arachidonic acid (AA)-induced platelet aggregation, are, at the moment, the most used tests to identify patients displaying high on-aspirin treatment platelet reactivity (HAPR). Both tests are specific for aspirin action on cyclooxygenase-1. While the correlation between serum TxB2 assay and clinical outcome is established, data are conflicting with regard to aspirin treatment and a possible association with AA-stimulated platelet markers and clinical outcome. To understand such discrepancy, we performed a retrospective study to compare both assays. We collected data from 132 patients receiving a daily dose of aspirin (100 mg/day) and data from 48 patients receiving aspirin on alternate days. All Patients who received a daily dose of aspirin were studied for AA-induced platelet aggregation together with serum TxB2 levels and AA-induced TxB2 formation was also studied in 71 patients out of entire population. Consistent with recommendations in the literature, we defined HAPR by setting a cut-off point at 3.1 ng/ml for serum levels of thromboxane B2 and 20% for AA-induced platelet aggregation. According to this cut-off point, we divided our overall population into two groups: (1) TxB2 < 3.1 ng/ml and (2) TxB2 > 3.1 ng/ml. We found low agreement between such tests to identify patients displaying HAPR. Our results show that AA-induced platelet aggregation >20% identify a smaller number of HAPR patients in comparison with TxB2. A good correlation between serum TxB2 and arachidonic acid-induced TxB2 production was found (r = 0.76619).

Arachidonic acid-stimulated platelet tests: Identification of patients less sensitive to aspirin treatment / Temperilli, Flavia; Rina, A.; Massimi, Isabella; Montemari, A. L.; Guarino, M. L.; Zicari, Alessandra; Pulcinelli, FABIO MARIA. - In: PLATELETS. - ISSN 0953-7104. - STAMPA. - 26:8(2015), pp. 783-787. [10.3109/09537104.2014.1003291]

Arachidonic acid-stimulated platelet tests: Identification of patients less sensitive to aspirin treatment

TEMPERILLI, FLAVIA;MASSIMI, ISABELLA;M. L. Guarino;ZICARI, Alessandra;PULCINELLI, FABIO MARIA
2015

Abstract

Serum thromboxane-B2 (TxB2), together with arachidonic acid (AA)-induced platelet aggregation, are, at the moment, the most used tests to identify patients displaying high on-aspirin treatment platelet reactivity (HAPR). Both tests are specific for aspirin action on cyclooxygenase-1. While the correlation between serum TxB2 assay and clinical outcome is established, data are conflicting with regard to aspirin treatment and a possible association with AA-stimulated platelet markers and clinical outcome. To understand such discrepancy, we performed a retrospective study to compare both assays. We collected data from 132 patients receiving a daily dose of aspirin (100 mg/day) and data from 48 patients receiving aspirin on alternate days. All Patients who received a daily dose of aspirin were studied for AA-induced platelet aggregation together with serum TxB2 levels and AA-induced TxB2 formation was also studied in 71 patients out of entire population. Consistent with recommendations in the literature, we defined HAPR by setting a cut-off point at 3.1 ng/ml for serum levels of thromboxane B2 and 20% for AA-induced platelet aggregation. According to this cut-off point, we divided our overall population into two groups: (1) TxB2 < 3.1 ng/ml and (2) TxB2 > 3.1 ng/ml. We found low agreement between such tests to identify patients displaying HAPR. Our results show that AA-induced platelet aggregation >20% identify a smaller number of HAPR patients in comparison with TxB2. A good correlation between serum TxB2 and arachidonic acid-induced TxB2 production was found (r = 0.76619).
2015
Aspirin; Platelet Aggregation; Thromboxane B2; Arachidonic Acid; COX-1
01 Pubblicazione su rivista::01a Articolo in rivista
Arachidonic acid-stimulated platelet tests: Identification of patients less sensitive to aspirin treatment / Temperilli, Flavia; Rina, A.; Massimi, Isabella; Montemari, A. L.; Guarino, M. L.; Zicari, Alessandra; Pulcinelli, FABIO MARIA. - In: PLATELETS. - ISSN 0953-7104. - STAMPA. - 26:8(2015), pp. 783-787. [10.3109/09537104.2014.1003291]
File allegati a questo prodotto
File Dimensione Formato  
Temperilli_Arachidonic-acid-stimulated_2015

solo gestori archivio

Note: articolo principale
Tipologia: Versione editoriale (versione pubblicata con il layout dell'editore)
Licenza: Tutti i diritti riservati (All rights reserved)
Dimensione 594.69 kB
Formato Adobe PDF
594.69 kB Adobe PDF   Contatta l'autore

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/11573/689461
Citazioni
  • ???jsp.display-item.citation.pmc??? 9
  • Scopus 15
  • ???jsp.display-item.citation.isi??? 14
social impact